Details of the Drug Formulations

General Information of Drug (ID: DM6Q7U4)

Drug Name
Lenalidomide Drug Info
Synonyms
Revamid; Revimid; Revlimid; Celgene brand of lenalidomide; Lenalidomide [USAN]; CC 5013; CC5013; CDC 501; IMiD3; IMiD3cpd; ALBB-015321; CC-5013; CDC-501; CDC-5013; ENMD-0997; IMID-5013; Revlimid (Celgene); Revlimid (TN); Thalidomide analog CC-5013; Lenalidomide (USAN/INN); CC-5013, Revlimid, Lenalidomide; 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione; 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; 3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione; 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione; Lenalidomide (Immunomodulator)
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Approved [1] , [2] , [3] , [4]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
216326
ChEBI ID
CHEBI:63791
CAS Number
191732-72-6
TTD ID
D0Q5NX
VARIDT ID
DR00261
ACDINA ID
D00353

Full List of Drug Formulations Containing This Drug

Lenalidomide 10 mg capsule
Company Formulation ID FDA Description
Celgene Corporation F11362 Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
------------------------------------------------------------------------------------
Lenalidomide 15 mg capsule
Company Formulation ID FDA Description
Celgene Corporation F11363 Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
------------------------------------------------------------------------------------
Lenalidomide 2.5 mg capsule
Company Formulation ID FDA Description
Celgene Corporation F11364 Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
------------------------------------------------------------------------------------
Lenalidomide 20 mg capsule
Company Formulation ID FDA Description
Celgene Corporation F11365 Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
------------------------------------------------------------------------------------
Lenalidomide 25 mg capsule
Company Formulation ID FDA Description
Celgene Corporation F11366 Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
------------------------------------------------------------------------------------
Lenalidomide 5 mg capsule
Company Formulation ID FDA Description
Celgene Corporation F11367 Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7331).
2 Emerging therapies for multiple myeloma. Expert Opin Emerg Drugs. 2009 Mar;14(1):99-127.
3 2005 approvals: Safety first. Nature Reviews Drug Discovery 5, 92-93 (February 2006).
4 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015